sym015: met antibody mixture for advanced solid tumors
Published 5 years ago • 188 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:36
sym015 shows superior specificity compared to tkis for nsclc
-
1:29
targeting siglec-15 with nc318 in siglec-15-positive advanced solid tumors
-
6:11
targeted therapy for advanced solid tumors based on molecular profiles: early results from mypathway
-
0:57
on203: the anti-oxmif antibody targeting solid tumors
-
49:07
a mucin 16 bispecific t cell-engaging antibody for the treatment of ovarian cancer
-
1:05:11
combinatorial immunotherapy approaches for patients with advanced solid tumors
-
8:44
2019 stat115 lect21.3 tumor immune infiltration
-
1:18
antibody discovery module: simply select better antibodies
-
38:46
a multi-omic single cell and spatial atlas of breast cancer reveals stromal suppression
-
32:34
tumor-derived antibodies for multifaceted immunotherapeutic targeting of human ovarian cancer
-
0:30
invitrogen proquantum high-sensitivity immunoassays - minimal sample consumption
-
1:24
new standard: combination immuno- and radiotherapy for advanced non-small cell lung cancer
-
0:47
mammomark® biopsy site identifier overview
-
1:36
dr. sosman on 3 mg/kg ipilimumab vs 10 mg/kg ipilimumab in metastatic melanoma
-
0:43
dr camidge on novel nsclc agents: we want to see the duration of benefit
-
2:57
io-io combinations in metastatic tnbc
-
2:31
oncomine tumor mutation load assay compared to foundationone test
-
28:59
high throughput secretomic analysis of single cells for systems immunology
-
3:24
impact of met inhibitors in met exon 14-mutant nsclc